
1. int j antimicrob agents. 2020 oct 9:106190. doi:
10.1016/j.ijantimicag.2020.106190. [epub ahead print]

absence association polymorphisms pfcoronin pfk13 genes and
the presence plasmodium falciparum parasites treatment artemisinin 
derivatives senegal.

delandre o(1), daffe sm(2), gendrot m(1), diallo mn(2), madamet m(3), kounta
mb(4), diop mn(5), bercion r(6), sow a(7), ngom pm(7), lo g(8), benoit n(3),
amalvict r(3), fonta i(3), mosnier j(3), diawara s(2), wade ka(4), fall m(5),
fall kb(9), fall b(2), pradines b(10).

author information: 
(1)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, marseille, france;
aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france; ihu méditerranée
infection, marseille, france.
(2)fédération des laboratories, hôpital principal de dakar, dakar, sénégal.
(3)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, marseille, france;
aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france; ihu méditerranée
infection, marseille, france; centre national de reference du paludisme,
marseille, france.
(4)service des urgences, hôpital principal de dakar, dakar, sénégal.
(5)service de réanimation médicale, hôpital principal de dakar, dakar, sénégal.
(6)laboratoire d'analyses médicales, institut pasteur de dakar, dakar, sénégal.
(7)service de maternité, hôpital principal de dakar, dakar, sénégal.
(8)centre medical inter-armées lemonier, dakar, sénégal; institut de recherche en
santé, de surveillance épidémiologique et de formation (iressef), dakar, sénégal.
(9)service de pathologies infectieuses, hôpital principal de dakar, dakar,
sénégal.
(10)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, marseille, france;
aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france; ihu méditerranée
infection, marseille, france; centre national de reference du paludisme,
marseille, france. electronic address: bruno.pradines@gmail.com.

due resistance chloroquine sulfadoxine-pyrimethamine, treatment for
uncomplicated plasmodium falciparum malaria switched artemisinin-based
combination therapy (act) 2006 senegal. several mutations gene
coding kelch13 helix (pfk13-propeller) identified associated 
in vitro vivo artemisinin resistance southeast asia. additionally,
three mutations pfcoronin gene (g50e, r100k e107v) been
identified two culture-adapted senegalese field isolates became
resistant vitro artemisinin 4 years intermittent selection with
dihydroartemisinin. aims study first assess prevalence of
pfcoronin pfk13 mutations senegalese field isolates dakar to
investigate association artemisinin derivatives clinical failures. a
total 348 samples p. falciparum 327 patients, collected 2015 to
2019 hôpital principal de dakar, successfully analyzed. sequences
had wild-type pfk13 allele. three mutations (g50e, r100k e107v),
previously identified reduced susceptibility parasites artemisinin, were
not found present study new mutation p76s detected (mean
prevalence 16.2%). p76s mutation identified 5 16 isolates
(31.3%) collected patients still parasitaemic day 3 act treatment
and 31 samples among 203 patients considered successfully cured
(15.3%). significant association vivo reduced efficacy to
artemisinin derivatives p76s mutation (p = 0.151; fisher's exact test).
the present data suggest polymorphisms pfk13 pfcoronin the
best predictive markers artemisinin resistance senegal.

copyright © 2020. published elsevier ltd.

doi: 10.1016/j.ijantimicag.2020.106190 
pmid: 33045351 

conflict interest statement: competing interests none declared.

